Ariane Tom, PhD

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.

Aurenar is a neurotechnology startup with a mission to transform the arc of care in intensive care units (ICUs) by reducing life-threatening and costly complications caused by inflammation. Beginning with stroke, and with numerous indications beyond, our non-invasive, single-use neuromodulation platform will fundamentally improve the lives of patients by minimizing complications, improving outcomes, and reducing the financial healthcare burden of these fragile patients.

Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale

Science Corporation is a clinical-stage medical technology company. We work to restore quality of life to those with debilitating conditions for which there are no treatment options, creating devices aimed at restoring vision, cognition, and mobility to patients who have lost it. To support progress across our industry, we provide state-of-the-art components and vertically integrated infrastructure for others to build on via Science Foundry. Headquartered in Alameda, California, with offices in Paris, France.

Resonant Link Medical is an innovative medical technology company redefining wireless power and data transfer for implantable medical devices to help people get well and stay well. Resonant Link Medical’s unmatched technology platform Aurion WPT™ delivers uninterrupted wireless power thats up to 10x faster than conventional wireless over double the range. The platform combines core innovations in coils, power electronics, magnetics, and data transfer capabilities to enable smaller, smarter, and longer-lasting devices that advance how we treat chronic conditions and make new therapies possible for the first time. If youre looking for unprecedented power performance and a faster, lower-risk path to market, reach out to info@rlmedical.com to learn whats possible for your device.

ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI.   Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.

Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale. Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.

Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

InterVenn was co-founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist, and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert Aldo Carrascoso on the belief that no one should ever be blindsided by disease. We are focused on decoding the glycoproteome as a rich source of biological insight. Thanks to the use of artificial intelligence (AI), we have pioneered a proprietary technology platform, GlycoVision™, to tap into this layer of biology at a clinically meaningful scale. GlycoVision is capable of producing a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and potentially therapeutics. The GlycoVision platform is accessible to industry partners seeking to discover novel biomarkers from as little as 50 µL of serum or plasma.

BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis. Through its single cell whole genome and whole transcriptome amplification tools, scientists and clinicians can gain an unprecedented view of the genome, transcriptome, and proteome within a single cell to better understand the drivers, mechanisms, and management of complex disease. The company is headquartered in Durham, North Carolina. For more information, visit bioskryb.com.

ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The companys proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic. To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.

Anzu Partners is a venture capital and private equity firm that invests in breakthrough industrial technologies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. Anzu Partners has offices in Washington, DC, San Diego, CA, Boston, MA, Atlanta, GA, and Tampa, FL.

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.

Aurenar is a neurotechnology startup with a mission to transform the arc of care in intensive care units (ICUs) by reducing life-threatening and costly complications caused by inflammation. Beginning with stroke, and with numerous indications beyond, our non-invasive, single-use neuromodulation platform will fundamentally improve the lives of patients by minimizing complications, improving outcomes, and reducing the financial healthcare burden of these fragile patients.

Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale

Science Corporation is a clinical-stage medical technology company. We work to restore quality of life to those with debilitating conditions for which there are no treatment options, creating devices aimed at restoring vision, cognition, and mobility to patients who have lost it. To support progress across our industry, we provide state-of-the-art components and vertically integrated infrastructure for others to build on via Science Foundry. Headquartered in Alameda, California, with offices in Paris, France.

Resonant Link Medical is an innovative medical technology company redefining wireless power and data transfer for implantable medical devices to help people get well and stay well. Resonant Link Medical’s unmatched technology platform Aurion WPT™ delivers uninterrupted wireless power thats up to 10x faster than conventional wireless over double the range. The platform combines core innovations in coils, power electronics, magnetics, and data transfer capabilities to enable smaller, smarter, and longer-lasting devices that advance how we treat chronic conditions and make new therapies possible for the first time. If youre looking for unprecedented power performance and a faster, lower-risk path to market, reach out to info@rlmedical.com to learn whats possible for your device.